CCL3



CCL3

A1AA1P2PP2Y3YY3G4GG4A5AA5D6DD6T7TT7P8PP8T9TT9A10AA10C11CC11C12CC12F13FF13S14SS14Y15YY15S16SS16R17RR17K18KK18I19II19P20PP20R21RR21Q22QQ22F23FF23I24II24V25VV25D26DD26Y27YY27F28FF28E29EE29T30TT30S31SS31S32SS32L33LL33C34CC34S35SS35Q36QQ36P37PP37G38GG38V39VV39I40II40F41FF41L42LL42T43TT43K44KK44R45RR45N46NN46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence APYGADTPTACCFSYSRKIPRQFIVDYFETSSLCSQPGVIFLTKRNRQICADSKETWVQEYITDLELNA

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL3

A1AA1P2PP2Y3YY3G4GG4A5AA5D6DD6T7TT7P8PP8T9TT9A10AA10C11CC11C12CC12F13FF13S14SS14Y15YY15S16SS16R17RR17K18KK18I19II19P20PP20R21RR21Q22QQ22F23FF23I24II24V25VV25D26DD26Y27YY27F28FF28E29EE29T30TT30S31SS31S32SS32L33LL33C34CC34S35SS35Q36QQ36P37PP37G38GG38V39VV39I40II40F41FF41L42LL42T43TT43K44KK44R45RR45N46NN46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.